Satyen K. Bordoloi My first memory of cancer is the younger brother of a classmate. Blood cancer, we whispered between ...

Francesca Vitelli and Orla Cloak from Minaris with Matthew Durdy, Eytan Abraham, and Dan Gibson of CGT Catapult.

Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality ...

Milestone Advances Clinical Readiness and Reinforces Urgent U.S. Need for Domestic MVA Vaccine Capacity ATLANTA, GA - ...

Authors explore complexities in scaling gene-therapy production with special attention is to monitoring and enhancing ...

The cell therapy manufacturing sector reached a pivotal inflection point in late 2025, with contract development and manufacturing ...

TechInvention Lifecare Limited has raised funding to develop a cutting-edge digital vaccine manufacturing unit in Navi Mumbai ...

Boston, Dec. 16, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Global Viral Vector Manufacturing Markets and Technologies Through 2030” is projected to grow from $6.3 ...

Leiden, The Netherlands – 11 December 2025 – ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G ...

Viral vector manufacturing continues to face challenges in delivering consistent quality and achieving high productivity at scale. This webinar will highlight how CDMO innovation drives improvements ...

COLLEGE STATION, Texas, Nov. 3, 2025 /PRNewswire/ -- Matica Biotechnology, Inc. ("Matica Bio"), a leading viral vector CDMO specializing in advanced therapies, today announced a strategic partnership ...